Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Suhas Solomon

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2014
Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, IndiaSunil Suhas Solomon, Aylur K Srikrishnan, Canjeevaram K Vasudevan, et al.
AIDS Research and Human Retroviruses|October 11, 2012
Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South IndiaShanmugam Saravanan, Vidya Madhavan, Pachamuthu Balakrishnan, et al.
Plos One|February 25, 2021
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional surveyAshwin Belludi, Allison M McFall, Sunil Suhas Solomon, et al.
The Lancet. HIV|April 3, 2016
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative studySunil Suhas Solomon, Shruti H Mehta, Allison M McFall, et al.
Journal of Infection and Public Health|November 23, 2021
Occurrence of extended-spectrum β-lactamase, AmpC, and carbapenemase-producing genes in gram-negative bacterial isolates from human immunodeficiency virus infected patientsMarimuthu Ragavan Rameshkumar, Narasingam Arunagirinathan, Balasubramanian Senthamilselvan, et al.
Plos One|October 31, 2019
Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?Ramnath Subbaraman, Beena E Thomas, Senthil Sellappan, et al.
Plos One|August 17, 2017
Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?Ramnath Subbaraman, Beena E Thomas, Senthil Sellappan, et al.
The Indian Journal of Medical Research|November 2, 2018
Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patientsDhakshinamoorthy Subashini, Thongadi Ramesh Dinesha, Rao B Srirama, et al.
Journal of Medical Microbiology|November 24, 2007
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settingsH Syed Iqbal, P Balakrishnan, Anitha J Cecelia, et al.
The Journal of International Medical Research|September 28, 2020
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settingsVairamohan Vidhyavathi, Hussain Syed Iqbal, Kannaiyan Kanthamani, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2014
Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, IndiaSunil Suhas Solomon, Aylur K Srikrishnan, Canjeevaram K Vasudevan, et al.
AIDS Research and Human Retroviruses|October 11, 2012
Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South IndiaShanmugam Saravanan, Vidya Madhavan, Pachamuthu Balakrishnan, et al.
Plos One|February 25, 2021
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional surveyAshwin Belludi, Allison M McFall, Sunil Suhas Solomon, et al.
The Lancet. HIV|April 3, 2016
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative studySunil Suhas Solomon, Shruti H Mehta, Allison M McFall, et al.
Journal of Infection and Public Health|November 23, 2021
Occurrence of extended-spectrum β-lactamase, AmpC, and carbapenemase-producing genes in gram-negative bacterial isolates from human immunodeficiency virus infected patientsMarimuthu Ragavan Rameshkumar, Narasingam Arunagirinathan, Balasubramanian Senthamilselvan, et al.
Plos One|October 31, 2019
Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?Ramnath Subbaraman, Beena E Thomas, Senthil Sellappan, et al.
Plos One|August 17, 2017
Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?Ramnath Subbaraman, Beena E Thomas, Senthil Sellappan, et al.
The Indian Journal of Medical Research|November 2, 2018
Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patientsDhakshinamoorthy Subashini, Thongadi Ramesh Dinesha, Rao B Srirama, et al.
Journal of Medical Microbiology|November 24, 2007
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settingsH Syed Iqbal, P Balakrishnan, Anitha J Cecelia, et al.
The Journal of International Medical Research|September 28, 2020
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settingsVairamohan Vidhyavathi, Hussain Syed Iqbal, Kannaiyan Kanthamani, et al.
Pageof 4